Manuel Sepulveda

Person

Princeton Junction, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Vaccines based on mutant CALR and JAK2 and their uses
- Patent number 12,018,289
- Issue date Jun 25, 2024
- Janssen Biotech, Inc.
- Ricardo Attar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Neoantigens expressed in ovarian cancer and their uses
- Patent number 11,945,881
- Issue date Apr 2, 2024
- Janssen Biotech, Inc.
- Vipul Bhargava
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD8A-binding fibronectin type III domains
- Patent number 11,932,680
- Issue date Mar 19, 2024
- Janssen Biotech, Inc.
- Rebecca Hawkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prostate neoantigens and their uses
- Patent number 11,793,843
- Issue date Oct 24, 2023
- Janssen Biotech, Inc.
- Kurtis E. Bachman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-L1 binding fibronectin type III domains
- Patent number 11,447,539
- Issue date Sep 20, 2022
- Janssen Biotech, Inc.
- Michael Diem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD137 binding fibronectin type III domains
- Patent number 11,345,739
- Issue date May 31, 2022
- Janssen Biotech, Inc.
- Michael Diem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD8A-binding fibronectin type III domains
- Patent number 11,299,534
- Issue date Apr 12, 2022
- Janssen Biotech, Inc.
- Rebecca Hawkins
- G01 - MEASURING TESTING
Information Patent Grant
CD8a-binding fibronectin type III domains
- Patent number 10,626,165
- Issue date Apr 21, 2020
- Janssen Biotech, Inc.
- Rebecca Hawkins
- G01 - MEASURING TESTING
Information Patent Grant
CD137 binding fibronectin type III domains
- Patent number 10,611,823
- Issue date Apr 7, 2020
- HANSSEN BIOTECH, INC
- Michael Diem
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-L1 binding fibronectin type III domains
- Patent number 10,597,438
- Issue date Mar 24, 2020
- Janssen Biotech, Inc.
- Michael Diem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD8A-Binding Fibronectin Type III Domains
- Publication number 20240301033
- Publication date Sep 12, 2024
- JANSSEN BIOTECH, INC.
- Rebecca Hawkins
- G01 - MEASURING TESTING
Information Patent Application
VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
- Publication number 20240294884
- Publication date Sep 5, 2024
- JANSSEN BIOTECH, INC.
- Ricardo ATTAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Neoantigens Expressed In Ovarian Cancer And Their Uses
- Publication number 20240254161
- Publication date Aug 1, 2024
- JANSSEN BIOTECH, INC.
- Vipul BHARGAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
- Publication number 20230285548
- Publication date Sep 14, 2023
- JANSSEN BIOTECH, INC.
- Patrick WILKINSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROSTATE CANCER VACCINES AND USES THEREOF
- Publication number 20230190903
- Publication date Jun 22, 2023
- JANSSEN BIOTECH, INC.
- Patrick WILKINSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD8A-Binding Fibronectin Type III Domains
- Publication number 20230143550
- Publication date May 11, 2023
- JANSSEN BIOTECH, INC.
- Rebecca Hawkins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CALR AND JAK2 T-CELL RECEPTORS
- Publication number 20230079750
- Publication date Mar 16, 2023
- JANSSEN BIOTECH, INC.
- Rebecca HANSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method For Determining Responsiveness To Prostate Cancer Treatment
- Publication number 20230035403
- Publication date Feb 2, 2023
- JANSSEN BIOTECH, INC.
- Denis A. Smirnov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prostate Neoantigens And Their Uses
- Publication number 20230029453
- Publication date Feb 2, 2023
- JANSSEN BIOTECH, INC.
- Jason Lee DeHart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prostate Neoantigens And Their Uses
- Publication number 20230024133
- Publication date Jan 26, 2023
- JANSSEN BIOTECH, INC.
- Jason Lee DeHart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20220259289
- Publication date Aug 18, 2022
- JANSSEN BIOTECH, INC.
- Michael Diem
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neoantigen Peptide Mimics
- Publication number 20220194999
- Publication date Jun 23, 2022
- JANSSEN BIOTECH, INC.
- Vinod Krishna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-VBETA17/ANTI-CD123 BISPECIFIC ANTIBODIES
- Publication number 20220127359
- Publication date Apr 28, 2022
- JANSSEN BIOTECH, INC.
- Rajkumar GANESAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA AND STEAP1 VACCINES AND THEIR USES
- Publication number 20210315986
- Publication date Oct 14, 2021
- JANSSEN BIOTECH, INC.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEOANTIGENS EXPRESSED IN OVARIAN CANCER AND THEIR USES
- Publication number 20210261609
- Publication date Aug 26, 2021
- JANSSEN BIOTECH, INC.
- Vipul BHARGAVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USES
- Publication number 20210261636
- Publication date Aug 26, 2021
- JANSSEN BIOTECH, INC.
- Vipul BHARGAVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
- Publication number 20210222133
- Publication date Jul 22, 2021
- JANSSEN BIOTECH, INC.
- Ricardo ATTAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD137 Binding Fibronectin Type III Domains
- Publication number 20210040180
- Publication date Feb 11, 2021
- JANSSEN BIOTECH, INC.
- Michael Diem
- G01 - MEASURING TESTING
Information Patent Application
CD8A-Binding Fibronectin Type III Domains
- Publication number 20210032312
- Publication date Feb 4, 2021
- JANSSEN BIOTECH, INC.
- Rebecca Hawkins
- G01 - MEASURING TESTING
Information Patent Application
PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20210024612
- Publication date Jan 28, 2021
- JANSSEN BIOTECH, INC.
- Michael Diem
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTATE NEOANTIGENS AND THEIR USES
- Publication number 20200222478
- Publication date Jul 16, 2020
- JANSSEN BIOTECH, INC.
- Kurtis E. Bachman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 Binding Fibronectin Type III Domains
- Publication number 20180162929
- Publication date Jun 14, 2018
- JANSSEN BIOTECH, INC.
- Michael Diem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD8A-Binding Fibronectin Type III Domains
- Publication number 20180162927
- Publication date Jun 14, 2018
- JANSSEN BIOTECH, INC.
- Rebecca Hawkins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PD-L1 Binding Fibronectin Type III Domains
- Publication number 20180162928
- Publication date Jun 14, 2018
- JANSSEN BIOTECH, INC.
- Michael Diem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Manuel Sepulveda

Person

Patents Grantslast 30 patents

Vaccines based on mutant CALR and JAK2 and their uses

Neoantigens expressed in ovarian cancer and their uses

CD8A-binding fibronectin type III domains

Prostate neoantigens and their uses

PD-L1 binding fibronectin type III domains

CD137 binding fibronectin type III domains

CD8A-binding fibronectin type III domains

CD8a-binding fibronectin type III domains

CD137 binding fibronectin type III domains

PD-L1 binding fibronectin type III domains

Patents Applicationslast 30 patents

CD8A-Binding Fibronectin Type III Domains

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

Neoantigens Expressed In Ovarian Cancer And Their Uses

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

PROSTATE CANCER VACCINES AND USES THEREOF

CD8A-Binding Fibronectin Type III Domains

CALR AND JAK2 T-CELL RECEPTORS

Method For Determining Responsiveness To Prostate Cancer Treatment

Prostate Neoantigens And Their Uses

Prostate Neoantigens And Their Uses

CD137 BINDING FIBRONECTIN TYPE III DOMAINS

Neoantigen Peptide Mimics

ANTI-VBETA17/ANTI-CD123 BISPECIFIC ANTIBODIES

PSMA AND STEAP1 VACCINES AND THEIR USES

NEOANTIGENS EXPRESSED IN OVARIAN CANCER AND THEIR USES

NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USES

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

CD137 Binding Fibronectin Type III Domains

CD8A-Binding Fibronectin Type III Domains

PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS

PROSTATE NEOANTIGENS AND THEIR USES

CD137 Binding Fibronectin Type III Domains

CD8A-Binding Fibronectin Type III Domains

PD-L1 Binding Fibronectin Type III Domains